Skip to main content
Top
Published in: Abdominal Radiology 6/2015

01-08-2015

A case of β-catenin-positive hepatocellular adenoma with MR imaging sign of diffuse intratumoral fat deposition

Authors: Masaya Ishii, Junichi Kazaoka, Junichi Fukushima, Mariko Gunji, Toru Aoyama, Toshio Fukusato, Keiji Sano, Fukuo Kondo, Toru Takeshita, Shigeru Furui, Masaaki Akahane

Published in: Abdominal Radiology | Issue 6/2015

Login to get access

Abstract

Hepatocellular adenoma (HCA) is a rare primary benign tumor of the liver, which occurs predominantly in young and middle-aged women. Recently, the subclassification of HCA was proposed by the Bordeaux group. Subsequently, characteristic radiological and clinical features have been revealed in each HCA subtype. According to the previous literature, diffuse intratumoral fat deposition is a very common finding in hepatocyte nuclear factor 1α-negative HCA, but this finding has been reported in β-catenin-positive HCA in the literature for only one case. In this case report, we report the second case of β-catenin-positive HCA with MR imaging sign of diffuse intratumoral fat deposition, confirmed immunohistologically on the basis of a surgical specimen. In addition, our case showed hypovascularity and isointensity on the hepatobiliary phase which have been reported as characteristic findings in β-catenin-positive HCA. Diffuse intratumoral fat deposition can be observed in β-catenin-positive HCA, which has a greater probability of malignant transformation than other types of HCA.
Literature
1.
go back to reference Purysko AS, Remer EM, et al. (2012) Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. AJR Am J Roentgenol 198:115–123PubMedCrossRef Purysko AS, Remer EM, et al. (2012) Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI. AJR Am J Roentgenol 198:115–123PubMedCrossRef
2.
go back to reference Grazioli L, Bondioni MP, et al. (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529PubMedCrossRef Grazioli L, Bondioni MP, et al. (2012) Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 262:520–529PubMedCrossRef
3.
go back to reference Bieze M, van den Esschert JW, et al. (2012) Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 199:26–34PubMedCrossRef Bieze M, van den Esschert JW, et al. (2012) Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium. AJR Am J Roentgenol 199:26–34PubMedCrossRef
4.
go back to reference van Aalten SM, Thomeer MGJ, et al. (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172–181PubMedCrossRef van Aalten SM, Thomeer MGJ, et al. (2011) Hepatocellular adenomas: correlation of MR imaging findings with pathologic subtype classification. Radiology 261:172–181PubMedCrossRef
6.
go back to reference Laumonier H, Bioulac-Sage P, et al. (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808–818PubMedCrossRef Laumonier H, Bioulac-Sage P, et al. (2008) Hepatocellular adenomas: magnetic resonance imaging features as a function of molecular pathological classification. Hepatology 48:808–818PubMedCrossRef
7.
go back to reference Laumonier H, Cailliez H, et al. (2012) Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings. AJR Am J Roentgenol 199:341–348PubMedCrossRef Laumonier H, Cailliez H, et al. (2012) Role of contrast-enhanced sonography in differentiation of subtypes of hepatocellular adenoma: correlation with MRI findings. AJR Am J Roentgenol 199:341–348PubMedCrossRef
8.
go back to reference Ronot M, Bahrami S, et al. (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182–1191PubMedCrossRef Ronot M, Bahrami S, et al. (2011) Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification. Hepatology 53:1182–1191PubMedCrossRef
9.
go back to reference Yoneda N, Matsui O, et al. (2012) Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol 30:777–782PubMedCrossRef Yoneda N, Matsui O, et al. (2012) Beta-catenin-activated hepatocellular adenoma showing hyperintensity on hepatobiliary-phase gadoxetic-enhanced magnetic resonance imaging and overexpression of OATP8. Jpn J Radiol 30:777–782PubMedCrossRef
10.
go back to reference Soejima Y, Kondo F, et al. (2012) Expression of OATP1B3 protein in subtypes of hepatocellular adenoma. Kanzo 53:779–780CrossRef Soejima Y, Kondo F, et al. (2012) Expression of OATP1B3 protein in subtypes of hepatocellular adenoma. Kanzo 53:779–780CrossRef
Metadata
Title
A case of β-catenin-positive hepatocellular adenoma with MR imaging sign of diffuse intratumoral fat deposition
Authors
Masaya Ishii
Junichi Kazaoka
Junichi Fukushima
Mariko Gunji
Toru Aoyama
Toshio Fukusato
Keiji Sano
Fukuo Kondo
Toru Takeshita
Shigeru Furui
Masaaki Akahane
Publication date
01-08-2015
Publisher
Springer US
Published in
Abdominal Radiology / Issue 6/2015
Print ISSN: 2366-004X
Electronic ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-014-0342-3

Other articles of this Issue 6/2015

Abdominal Radiology 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.